 |
|
|
|
|
Erkrankungen & Symptome
Borreliose
Die Lyme-Borreliose oder Lyme-Krankheit ist eine multisystemische Infektionskrankheit, die durch das Bakterium Borrelia burgdorferi aus der Gruppe der Spirochäten ausgelöst wird. Es kann jedes Organ, das Nervensystem, die Gelenke und das Gewebe befallen werden. Die Erkrankung kommt beim Menschen und allen anderen Säugetieren sowie Vögeln vor. Die Übertragung erfolgt vor allem durch den Holzbock, eine Zeckenart; sehr selten auch durch Stechmücken oder Pferdebremsen.
In der Auflistung folgender Symptome kann sich vermutlich ohne weiteres jedermann wiederfinden, sogar Gesunde. Es geht gar nicht darum, ein Krankheitsbild zu umreißen, das Borreliose von anderen Krankheiten abgrenzt. Es geht darum, darauf hinzuweisen, dass sich Borreliose hinter sehr vielen existierenden Krankheitsbildern und Diagnosegewohnheiten verstecken kann.
- Chronische Müdigkeit
- Fehlende Ausdauer
- Wiederkehrendes Fieber, Nachtschweiß, Kältegefühl, Hitzwallungen
- Nicht-heilende Kieferknochen, Absterben der Zähne
- Gelenksteife
- Gelenkentzündungen
- Muskelschmerz
- Brennen, Taubheitsgefühl, stechender Schmerz
- Muskelkrämpfe und Zuckungen
- Probleme im Hirnnervenbereich (Gesichtsteillähmung, Geräuschempfindlichkeit, Tinnitus, Kopfschmerz, Gleichgewichtsstörungen, verschwommene Sicht, Doppelsehen
- Probleme im Zentralnervensystem (Epilepsie, Tremor, Schlafstörungen, Stimmungsschwankungen, Wutanfälle, Depressionen, Denkstörungen, Konzentrationsmangel, Kurzzeitgedächtnis gestört, Probleme bei der Wortfindung und Lesen, Orientierungsschwierigkeiten)
- Geschwollene Lymphknoten
- Schmerzen in der Brust
- Chronische Magenbeschwerden
- Verstopfung und Durchfall
- Rippenschmerzen bei leichtem/keinem Druck, Husten Kurzatmigkeit
- Herz: Palpitationen, Rhytmusstörungen, Mitralklappenprolaps
- Versagen des Immunsystems mit entsprechenden Sekundärerkrankungen
- Haarausfall
Fachliteratur
|
Brian Fallon: Die neuropsychiatrischen Manifestationen der Lyme-Borreliose Übersetzung der englischsprachigen Version 1992
Hans-Peter Wirtz: Zecken als Krankheitsüberträger: Was tun bei einem Stich? In: Biologie in unserer Zeit. Jg. 2001, Bd. 31, Nr. 4, S. 229-238.
Helge Kampen: Vektor-übertragene Infektionskrankheiten auf dem Vormarsch? Wie Umweltveränderungen Krankheitsüberträgern und -erregern den Weg bereiten. In: Naturwissenschaftliche Rundschau. Jg. 2005, Bd. 58, Nr. 4, S. 181-189.
H. Krauss et al.: Borreliosen. In: Zoonosen. Von Tier zu Mensch übertragbare Infektionskrankheiten. 3. Auflage, 2004, Deutscher ärzteverlag.
Dieter Hassler: Phasengerechte Therapie der Lyme-Borreliose In: Chemother. J. Jg. 2006, Bd. 15, S. 106-111.
C. Rauter et al.: Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR. In: J. Clin. Microbiol. Jg. 2002, Bd. 40, S. 36-43.
W. Klemann: Gastrointestinale Manifestationen der Borreliose und zu beachtende Co-Infektionen. 2005
Nau, R. et al.: "Lyme-Borreliose - aktueller Kenntnisstand." Dtsch Arztebl Int 2009; 106(5): S. 72-81
Brian Fallon: Die neuropsychiatrischen Manifestationen der Lyme-Borreliose übersetzung der englischsprachigen Version 1992
Hans-Peter Wirtz: Zecken als Krankheitsüberträger: Was tun bei einem Stich? In: Biologie in unserer Zeit. Jg. 2001, Bd. 31, Nr. 4, S. 229-238.
Helge Kampen: Vektor-übertragene Infektionskrankheiten auf dem Vormarsch? Wie Umweltveränderungen Krankheitsüberträgern und -erregern den Weg bereiten. In: Naturwissenschaftliche Rundschau. Jg. 2005, Bd. 58, Nr. 4, S. 181-189.
H. Krauss et al.: Borreliosen. In: Zoonosen. Von Tier zu Mensch übertragbare Infektionskrankheiten. 3. Auflage, 2004, Deutscher ärzteverlag
Dieter Hassler: Phasengerechte Therapie der Lyme-Borreliose In: Chemother. J. Jg. 2006, Bd. 15, S. 106-111.
C. Rauter et al.: Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR. In: J. Clin. Microbiol. Jg. 2002, Bd. 40, S. 36-43.
W. Klemann: Gastrointestinale Manifestationen der Borreliose und zu beachtende Co-Infektionen. 2005
Nau, R. et al.: "Lyme-Borreliose - aktueller Kenntnisstand." Dtsch Arztebl Int 2009; 106(5): S. 72-81
International Lyme and Associated Diseases Society (2004). Evidence-based guidelines for the management of Lyme disease. Expert Review of Anti-Infective Therapy, 2(Suppl 1): S1-S13.
Edlow JA (2002). Erythema migrans section of Tick-borne diseases. Medical Clinics of North America, 86(2): 239-260.
Smith RP, et al. (2002). Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Annals of Internal Medicine, 136: 421-428.
Hwang MI (2000). Dangers of Lyme disease. JAMA, 283(5): 698.
Nadelman RB (2001). Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New England Journal of Medicine, 345(2).
Wormser GP, et al. (2003). Duration of antibiotic therapy for early Lyme disease. Annals of Internal Medicine, 138: 697-704.
Eppes SC, et al. (2002). Comparative study of cefuroximine axetil versus amoxicillin in children with early Lyme disease. Pediatrics, 109(6): 1173-1176.
Hayes E, Mead P (2005). Lyme disease. Clinical Evidence (13): 947-955.
Hayes EB, Piesman J (2003). How can we prevent Lyme disease? New England Journal of Medicine, 348: 2424-2430.
Tompkins DC, Luft BJ (2005). Lyme disease and other spirochetal zoonoses. In DC Dale et al., eds., ACP Medicine, section 7, chap. 7. New York: WebMD.
Satz N: Klinik der Lyme-Borreliose. Verlag Hans Huber, Bern, 2. Auflage, 2002.
Lünemann JD, Gelderblom H, Sospedra M, Quandt JA, Pinilla C, Marques A, Martin R: Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early Lyme encephalitis. Infect Immun 2007; 75: 243-51.
Ohlenbusch A, Matuschka F-R, Richter D, Christen H-J, Thomssen R, Spielman A, Eiffert H: Etiology of the Acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 1996; 174: 421-3.
Wilske B, Busch U, Eiffert H, Fingerle V, Pfister HW, Rössler D, Preac-Mursic V: Diversitiy of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol 1996; 184: 195-201.
Robert-Koch-Institut. RKI Ratgeber Infektionskrankheiten "Lyme-BorrelioseŇ 2007.
Wilske B, Fingerle V: Lyme-Borreliose Diagnostik. Mikrobiologe 2005; 15: 209-20.
Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA: Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 697-703.
Christen H-J, Eiffert H: Lyme-Borreliose: Haut- und Nervensystem. Monatschr Kinderheilk 2003; 151: 1146-55.
Christen HJ, Hanefeld F, Eiffert H, Thomssen R: Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl 1993; 386: 1-75.
Ackermann R, Golmer E, Rehse-Küpper B: Progressive Borrelien-Enzephalomyelitis. Dtsch Med Wochenschr 1985; 110: 1039-42.
Miklossy J, Kuntzer T, Bogousslavsky J, Regli F, Janzer RC: Meningovascular form of neuroborreliosis: similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol 1990; 80: 568-72.
Eiffert H, Karsten A, Schlott T, Ohlenbusch A, Laskawi R, Hoppert M, Christen HJ: Acute peripheral facial palsy in Lyme disease - a distal neuritis at the infection site. Neuropediatrics 2004; 35: 267-73.
Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB, Stanek G, Pfister HW: MiQ12 2000 Lyme-Borreliosis
Kaiser R, Kölmel HW, Pfister HW, Rauer S, Wilske B: Neuroborreliose (Leitlinie der Deutschen Gesellschaft für Neurologie). In Diener HC et al. (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl, Thieme, Stuttgart 2005.
Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP: Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18: 484-509.
Kaiser R: Verlauf der akuten und chronischen Neuroborreliose nach Behandlung mit Ceftriaxon. Nervenarzt 2004; 75: 553-7.
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC et al.: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis and babesiosis: Clinical practice guidelines by the infectious diseases society of America. IDSA Giudelines 2006; 43: 1089-134.
Feder HM, Johnson BJB, O«Connell et al.: A critical appraisal of "chronic lyme disease". N Engl J Med 2007; 357: 1422-30.
Nau R, Prange HW, Muth P, Mahr G, Menck S, Kolenda H, Sörgel F: Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 1993; 37: 1518-24.
Krupp LB, Masur D, Schwartz J, Coyle PK, Langenbach LJ, Fernquist SK, Jandorf L, Halperin JJ: Cognitive function in late Lyme borreliosis. Arch Neurol 1991; 48: 1125-9.
Auwaerter PG: Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to lyme disease. Clin Infect Dis 2007; 45: 143-8.
Krupp LB, Hyman LG, Grimson R et al.: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003; 60: 1923-30.
Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED: Long-term outcomes of persons with Lyme disease. J Am Med Assoc 2000; 283: 609-16.
Stricker RB. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease. Clin Infect Dis 2007; 45: 149-57.
Eiffert H, Karsten A, Ritter K, Ohlenbusch A, Schlott T, Laskawi R, Christen HJ: Autoantibodies to human manganese superoxide dismutase (MnSOD) in children with facial palsy due to neuroborreliosis. Neuropediatrics 2005; 36: 386-8.
Wormser G: Early Lyme disease. New Engl J Med 2006; 354: 2794-801.
Kohlhepp W, Kuhn W, Krüger H: Extrapyramidal features in central Lyme borreliosis. Eur Neurol 1989; 29: 150-5.
Dinser R, Jendro MC, Schnarr S, Zeidler H: Antibiotic treatment of Lyme borreliosis: what is the evidence? Ann Rheum Dis 2005; 64: 519-23.
Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC: Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis 2001; 183: 453-60.
Steere AC, Malawista SE, Newman JH, Spieler PN, Bartenhagen NH: Antibiotic therapy in Lyme disease. Ann Intern Med 1980; 93: 1-8.
Halperin JJ, Shapiro ED, Logigian E et al.: Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007; 69: 91-102.
Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. pp. 434-437. ISBN 0838585299.
Johnson RC (1996). "Borrelia". Baron's Medical Microbiology (Baron S et al, eds.) (4th ed. ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1.
Cairns V, Godwin J (2005). "Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms". Int J Epidemiol 34 (6): 1340-1345. doi:10.1093/ije/dyi129
Stricker RB (July 2007). "Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45 (2): 149-57. doi:10.1086/518853.
Klempner MS, Hu LT, Evans J, et al (July 2001). "Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease". N. Engl. J. Med. 345 (2): 85-92.
Kaplan RF, Trevino RP, Johnson GM, et al (June 2003). "Cognitive function in post-treatment Lyme disease: do additional antibiotics help?". Neurology 60 (12): 1916-22.
Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA (March 2008). "["http://neurology.org/cgi/content/abstract/70/13/992" A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy]". Neurology 70 (13): 992-1003. doi:10.1212/01.WNL.0000284604.61160.2d.
Krupp LB, Hyman LG, Grimson R, et al (June 2003). "Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial". Neurology 60 (12): 1923-30.
Feder HM, Johnson BJ, O'Connell S, et al (October 2007). "A critical appraisal of "chronic Lyme disease"". N. Engl. J. Med. 357 (14): 1422-30. doi:10.1056/NEJMra072023.
Frequently Asked Questions about Lyme Disease, from the Infectious Diseases Society of America. Released October 2006; accessed June 24, 2008.
Edlow JA (2007-01-25). "Lyme disease". eMedicine.
Steere AC, Sikand VK, Schoen RT, Nowakowski J (2003). "Asymptomatic infection with Borrelia burgdorferi". Clin. Infect. Dis. 37 (4): 528-532. doi:10.1086/376914.
Fahrer H, Sauvain MJ, Zhioua E, Van Hoecke C, Gern LE (1998). "Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals?". Eur. J. Epidemiol. 14 (2): 117-123.
Fauci, Anthony S. (2008). Harrison's Principles of Internal Medicine: Editors, Anthony S. Fauci ... [Et Al.]. McGraw-Hill Medical Publishing. pp. Chapter 166. ISBN 0-07-159991-6.
Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, Holman MS, Persing DH, Steere AC (March 2002). "Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans". Ann. Intern. Med. 136 (6): 421-428.
Auwaerter PG, Aucott J, Dumler JS (January 2004). "Lyme borreliosis (Lyme disease): molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment". Expert Rev Mol Med 6 (2): 1-22. doi:10.1017/S1462399404007276.
Steere AC, Dhar A, Hernandez J, et al (January 2003). "Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease". Am. J. Med. 114 (1): 58-62.
Dandache P, Nadelman RB (June 2008). "Erythema migrans". Infect. Dis. Clin. North Am. 22 (2): 235-60, vi. doi:10.1016/j.idc.2007.12.012.
Stanek G, Strle F (June 2008). "Lyme disease: European perspective". Infect. Dis. Clin. North Am. 22 (2): 327-39, vii. doi:10.1016/j.idc.2008.01.001.
Chabria SB, Lawrason J (2007). "Altered mental status, an unusual manifestation of early disseminated Lyme disease: A case report". Journal of Medical Case Reports 1 (1): 62. doi:10.1186/1752-1947-1-62.
Shadick NA, Phillips CB, Sangha O, et al (December 1999). "Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease". Ann. Intern. Med. 131 (12): 919-26.
Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED (February 2000). "Long-term outcomes of persons with Lyme disease". JAMA 283 (5): 609-16.
Fallon BA, Nields JA (1994). "Lyme disease: a neuropsychiatric illness". The American journal of psychiatry 151 (11): 1571-1583.
Hess A, Buchmann J, Zettl UK, et al (1999). "Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenia-like disorder". Biol. Psychiatry 45 (6): 795. doi:10.1016/S0006-3223(98)00277-7.
Puius YA, Kalish RA (June 2008). "Lyme arthritis: pathogenesis, clinical presentation, and management". Infect. Dis. Clin. North Am. 22 (2): 289-300, vi-vii. doi:10.1016/j.idc.2007.12.014.
Wang G, van Dam AP, Schwartz I, Dankert J (October 1999). "Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications". Clin. Microbiol. Rev. 12 (4): 633-53.
Derd‡kov‡ M, Lenc‡kov‡ D (2005). "Association of genetic variability within the Borrelia burgdorferi sensu lato with the ecology, epidemiology of Lyme borreliosis in Europe". Ann Agric Environ Med 12 (2): 165-72.
Bunikis J, Garpmo U, Tsao J, Berglund J, Fish D, Barbour AG (2004). "Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe" (PDF). Microbiology 150 (Pt 6): 1741-1755. doi:10.1099/mic.0.26944-0.
Schneider BS, Schriefer ME, Dietrich G, Dolan MC, Morshed MG, Zeidner NS (October 2008). "Borrelia bissettii isolates induce pathology in a murine model of disease". Vector Borne Zoonotic Dis. 8 (5): 623-33. doi:10.1089/vbz.2007.0251.
Rudenko N, Golovchenko M, Mokr‡cek A, et al (October 2008). "Detection of Borrelia bissettii in cardiac valve tissue of a patient with endocarditis and aortic valve stenosis in the Czech Republic". J. Clin. Microbiol. 46 (10): 3540-3. doi:10.1128/JCM.01032-08.
Steere AC (July 2001). "Lyme disease". N. Engl. J. Med. 345 (2): 115-25.
Wormser G, Masters E, Nowakowski J, et al (2005). "Prospective clinical evaluation of patients from missouri and New York with erythema migrans-like skin lesions". Clin Infect Dis 41 (7): 958-965. doi:10.1086/432935.
Ledin KE, et al (2005). "Borreliacidal activity of saliva of the tick Amblyomma americanum". Med Vet Entomol 19 (1): 90-95. doi:10.1111/j.0269-283X.2005.00546.x
Masters EJ, Grigery CN, Masters RW (June 2008). "STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness". Infect. Dis. Clin. North Am. 22 (2): 361-76, viii. doi:10.1016/j.idc.2007.12.010.
Clark K (2004). "Borrelia species in host-seeking ticks and small mammals in northern Florida" (PDF). J Clin Microbiol 42 (11): 5076-5086. doi:10.1128/JCM.42.11.5076-5086.2004.
Eisen L, Eisen RJ, Lane RS (2004). "The roles of birds, lizards, and rodents as hosts for the western black-legged tick Ixodes pacificus". J. Vector Ecol. 29 (2): 295-308.
Lane RS, Mun J, Eisen L, Eisen RJ (2006). "Refractoriness of the western fence lizard (Sceloporus occidentalis) to the Lyme disease group spirochete Borrelia bissettii". J. Parasitol. 92 (4): 691-696.
Magnarelli L, Anderson J (1988). "Ticks and biting insects infected with the etiologic agent of Lyme disease, Borrelia burgdorferi" (PDF). J Clin Microbiol 26 (8): 1482-1486.
Luger S (1990). "Lyme disease transmitted by a biting fly". N Engl J Med 322 (24): 1752.
Bach G (2001). "Recovery of Lyme spirochetes by PCR in semen samples of previously diagnosed Lyme disease patients.". 14th International Scientific Conference on Lyme Disease.
Schmidt B, Aberer E, Stockenhuber C, et al (1995). "Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis". Diagn Microbiol Infect Dis 21 (3): 121-128. doi:10.1016/0732-8893(95)00027-8.
Steere AC (2003-02-01). "Lyme Disease: Questions and Answers" (PDF). Massachusetts General Hospital / Harvard Medical School. http://www.mgh.harvard.edu/medicine/rheu/Q&ALYME.pdf
Walsh CA, Mayer EW, Baxi LV (2007). "Lyme disease in pregnancy: case report and review of the literature". Obstetrical & gynecological survey 62 (1): 41-50. doi:10.1097/01.ogx.0000251024.43400.9a.
Wormser GP (June 2006). "Clinical practice. Early Lyme disease". N. Engl. J. Med. 354 (26): 2794-801. doi:10.1056/NEJMcp061181.
Varde S, Beckley J, Schwartz I (1998). "Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County". Emerging Infect. Dis. 4 (1): 97-9.
Brown SL, Hansen SL, Langone JJ (1999). "Role of serology in the diagnosis of Lyme disease". JAMA 282 (1): 62-66. doi:10.1001/jama.282.1.62.
Hofmann H (1996). "Lyme borreliosisŃproblems of serological diagnosis". Infection 24 (6): 470-472. doi:10.1007/BF01713052.
Pachner AR (1989). "Neurologic manifestations of Lyme disease, the new "great imitator"". Rev. Infect. Dis. 11 Suppl 6: S1482-1486.
Engstrom SM, Shoop E, Johnson RC (1995). "Immunoblot interpretation criteria for serodiagnosis of early Lyme disease"
Sivak SL, Aguero-Rosenfeld ME, Nowakowski J, Nadelman RB, Wormser GP (1996). "Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease". Arch Intern Med 156 (18): 2105-2109. doi:10.1001/archinte.156.18.2105.
Goossens HA, Nohlmans MK, van den Bogaard AE (1999). "Epstein-Barr virus and cytomegalovirus infections cause false-positive results in IgM two-test protocol for early Lyme borreliosis". Infection 27 (3): 231. doi:10.1007/BF02561539.
Strasfeld L, Romanzi L, Seder RH, Berardi VP (2005). "False-positive serological test results for Lyme disease in a patient with acute herpes simplex virus type 2 infection". Clin Infect Dis 41 (12): 1826-1827. doi:10.1086/498319.
Molloy PJ, Persing DH, Berardi VP (2001). "False-positive results of PCR testing for Lyme disease". Clin. Infect. Dis. 33 (3): 412-413.
Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP (2005). "Diagnosis of Lyme borreliosis". Clin. Microbiol. Rev. 18 (3): 484-509. doi:10.1128/CMR.18.3.484-509.2005.
Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC (1994). "Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis". N. Engl. J. Med. 330 (4): 229-234.
Burdash N, Fernandes J (1991). "Lyme borreliosis: detecting the great imitator". The Journal of the American Osteopathic Association 91 (6): 573-574, 577-578.
Coyle PK, Schutzer SE, Deng Z, et al (1995). "Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease". Neurology 45 (11): 2010-2015.
Valentine-Thon E, Ilsemann K, Sandkamp M (2007). "A novel lymphocyte transformation test (LTT-MELISA) for Lyme borreliosis". Diagn. Microbiol. Infect. Dis. 57 (1): 27-34. doi:10.1016/j.diagmicrobio.2006.06.008.
Eisendle K, Grabner T, Zelger B (2007). "Focus floating microscopy: "gold standard" for cutaneous borreliosis?". Am. J. Clin. Pathol. 127 (2): 213-222. doi:10.1309/3369XXFPEQUNEP5C.
Cadavid D (2006). "The mammalian host response to borrelia infection". Wien. Klin. Wochenschr. 118 (21-22): 653-658. doi:10.1007/s00508-006-0692-0
Sumiya H, Kobayashi K, Mizukoshi C, et al (1997). "Brain perfusion SPECT in Lyme neuroborreliosis". J. Nucl. Med. 38 (7): 1120-1122.
Logigian EL, Johnson KA, Kijewski MF, et al (1997). "Reversible cerebral hypoperfusion in Lyme encephalopathy". Neurology 49 (6): 1661-1670.
Fallon BA, Das S, Plutchok JJ, Tager F, Liegner K, Van Heertum R (1997). "Functional brain imaging and neuropsychological testing in Lyme disease". Clin. Infect. Dis. 25 Suppl 1: S57-63.
Fallon, BA (2000). "Review of Lyme Neuroborreliosis" in 3th International Scientific Conference on Lyme Disease and other Tick-borne Disorders..
Kalina P, Decker A, Kornel E, Halperin JJ (2005). "Lyme disease of the brainstem". Neuroradiology 47 (12): 903-907. doi:10.1007/s00234-005-1440-2.
Fallon BA, Keilp J, Prohovnik I, Heertum RV, Mann JJ (2003). "Regional cerebral blood flow and cognitive deficits in chronic Lyme disease". The Journal of neuropsychiatry and clinical neurosciences 15 (3): 326-332.
Piesman J, Dolan MC (2002). "Protection against Lyme disease spirochete transmission provided by prompt removal of nymphal Ixodes scapularis (Acari: Ixodidae)". J Med Entomol 39 (3): 509-512.
Duffy, DC; Downer R, Brinkley C (June 1992). "The effectiveness of Helmeted Guineafowl in the control of the deer tick, the vector of Lyme disease" (PDF). The Wilson Bulletin 104 (2): 342-45. http://www.guineafowl.com/fritsfarm/guineas/ticks/tickstudy.pdf.
Rand PW, Lubelczyk C, Holman MS, Lacombe EH, Smith RP (2004). "Abundance of Ixodes scapularis (Acari: Ixodidae) after the complete removal of deer from an isolated offshore island, endemic for Lyme Disease". J. Med. Entomol. 41 (4): 779-784.
"Managing Urban Deer in Connecticut, Figure 2, p.4." (PDF). 2nd edition. Connecticut Department of Environmental Protection - Wildlife Division. June 2007. http://www.ct.gov/dep/lib/dep/wildlife/pdf_files/game/urbandeer07.pdf.
Stafford KC (2004). "Tick Management Handbook" (PDF). Connecticut Agricultural Experiment Station and Connecticut Department of Public Health. 46. http://www.ct.gov/caes/lib/caes/documents/special_features/TickHandbook.pdf.
Poland GA, Jacobson RM (March 2001). "The prevention of Lyme disease with vaccine". Vaccine 19 (17-19): 2303-8.
Lukewarm Response To New Lyme Vaccine, by Claudia Rowe. Published in the New York Times on June 13, 1999; accessed July 11, 2008.
Abbott A (February 2006). "Lyme disease: uphill struggle". Nature 439 (7076): 524-5. doi:10.1038/439524a.
Sole Lyme Vaccine Is Pulled Off Market, published in the New York Times on February 28, 2002; accessed July 11, 2008.
Nigrovic LE, Thompson KM (January 2007). "The Lyme vaccine: a cautionary tale". Epidemiol. Infect. 135 (1): 1-8. doi:10.1017/S0950268806007096.
"When a vaccine is safe". Nature 439 (7076): 509. February 2006. doi:10.1038/439509a
Earnhart CG, Marconi RT (2007). "An octavalent Lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences". Hum Vaccin 3 (6): 281-9.
Pozsgay V, Kubler-Kielb J (2007). "Synthesis of an experimental glycolipoprotein vaccine against Lyme disease". Carbohydr. Res. 342 (3-4): 621-626. doi:10.1016/j.carres.2006.11.014.
Zeller JL, Burke AE, Glass RM (2007). "JAMA patient page. Lyme disease". JAMA 297 (23): 2664. doi:10.1001/jama.297.23.2664
Oksi J, Nikoskelainen J, Hiekkanen H, et al (2007). "Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study". Eur. J. Clin. Microbiol. Infect. Dis. 26 (8): 571-581. doi:10.1007/s10096-007-0340-2.
Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC (April 2006). "Minocycline for short-term neuroprotection". Pharmacotherapy 26 (4): 515-21. doi:10.1592/phco.26.4.515.
Halperin JJ (2008). "Prolonged Lyme disease treatment: Enough is enough". Neurology 70 (13): 986-7.
Cameron D, Gaito A, Harris N, et al (2004 url="http://www.guideline.gov/summary/summary.aspx?doc_id=4836&nbr=3481&string=lyme"). "Evidence-based guidelines for the management of Lyme disease". Expert Rev Anti Infect Ther 2 (1 Suppl): S1-13.
Baker PJ (2008). "Perspectives on ŇChronic Lyme DiseaseÓ". American Journal of Medicine 121 (7): 562-4.
Wormser GP, Dattwyler RJ, Shapiro ED, et al (November 2006). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clin. Infect. Dis. 43 (9): 1089-134. doi:10.1086/508667.
Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT (2007). "Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology 69 (1): 91-102. doi:10.1212/01.wnl.0000265517.66976.28.
Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM (October 2000). "Death from inappropriate therapy for Lyme disease". Clin. Infect. Dis. 31 (4): 1107-9.
Oksi J, Marjamäki M, Nikoskelainen J, Viljanen MK (1999). "Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis". Ann. Med. 31 (3): 225-232. doi:10.3109/07853899909115982.
Hartiala P, Hytönen J, Pelkonen J, et al (2007). "Transcriptional response of human dendritic cells to Borrelia gariniiŃdefective CD38 and CCR7 expression detected". J. Leukoc. Biol. 82 (1): 33-43. doi:10.1189/jlb.1106709.
Massarotti EM (2002). "Lyme arthritis". Med. Clin. North Am. 86 (2): 297-309. doi:10.1016/S0025-7125(03)00088-9.
Steere AC, Angelis SM (October 2006). "Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis". Arthritis Rheum. 54 (10): 3079-86. doi:10.1002/art.22131.
Weissenbacher S, Ring J, Hofmann H (2005). "Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study". Dermatology (Basel) 211 (2): 123-127. doi:10.1159/000086441.
Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M (2004). "Clinical potential of minocycline for neurodegenerative disorders". Neurobiol. Dis. 17 (3): 359-366. doi:10.1016/j.nbd.2004.07.012.
Taylor R, Simpson I (2005). "Review of treatment options for Lyme borreliosis". J Chemother 17 Suppl 2: 3-16.
Pavia C (2003). "Current and novel therapies for Lyme disease". Expert Opin Investig Drugs 12 (6): 1003-1016. doi:10.1517/13543784.12.6.1003.
Schardt FW (2004). "Clinical effects of fluconazole in patients with neuroborreliosis". Eur. J. Med. Res. 9 (7): 334-336.
Lubke LL, Garon CF (1997). "The antimicrobial agent melittin exhibits powerful in vitro inhibitory effects on the Lyme disease spirochete". Clin. Infect. Dis. 25 Suppl 1: S48-51.
Krause PJ, Foley DT, Burke GS, Christianson D, Closter L, Spielman A (2006). "Reinfection and relapse in early Lyme disease". Am. J. Trop. Med. Hyg. 75 (6): 1090-1094.
Klempner MS, Hu LT, Evans J, et al (2001). "Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease". N Engl J Med 345 (2): 85-92. doi:10.1056/NEJM200107123450202.
Kirsch M, Ruben FL, Steere AC, Duray PH, Norden CW, Winkelstein A (1988). "Fatal adult respiratory distress syndrome in a patient with Lyme disease". JAMA 259 (18): 2737-2739. doi:10.1001/jama.259.18.2737.
Oksi J, Kalimo H, Marttila RJ, et al (1996). "Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature". Brain 119 (Pt 6): 2143-2154. doi:10.1093/brain/119.6.2143.
Waniek C, Prohovnik I, Kaufman MA, Dwork AJ (1995). "Rapidly progressive frontal-type dementia associated with Lyme disease". J Neuropsychiatry Clin Neurosci 7 (3): 345-347.
Cary NR, Fox B, Wright DJ, Cutler SJ, Shapiro LM, Grace AA (1990). "Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node". Postgrad Med J 66 (772): 134-136.
LoGiudice K, Ostfeld R, Schmidt K, Keesing F (2003). "The ecology of infectious disease: effects of host diversity and community composition on Lyme disease risk". Proc Natl Acad Sci U S A 100 (2): 567-571. doi:10.1073/pnas.0233733100.
Patz J, Daszak P, Tabor G, et al (2004). "Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence". Environ Health Perspect 112 (10): 1092-1098.
Khasnis AA, Nettleman MD (2005). "Global warming and infectious disease". Arch. Med. Res. 36 (6): 689-696. doi:10.1016/j.arcmed.2005.03.041.
Perkins SE, Cattadori IM, Tagliapietra V, Rizzoli AP, Hudson PJ (2006). "Localized deer absence leads to tick amplification". Ecology 87 (8): 1981-1986. doi:10.1890/0012-9658(2006)87[1981:LDALTT]2.0.CO;2.
Swanson KI, Norris DE (2007). "Detection of Borrelia burgdorferi DNA in lizards from Southern Maryland". Vector Borne Zoonotic Dis. 7 (1): 42-49. doi:10.1089/vbz.2006.0548.
Richter D, Matuschka FR (July 2006). "Perpetuation of the Lyme disease spirochete Borrelia lusitaniae by lizards". Appl. Environ. Microbiol. 72 (7): 4627-4632. doi:10.1128/AEM.00285-06.
Giery ST, Ostfeld RS (June 2007). "The role of lizards in the ecology of Lyme disease in two endemic zones of the northeastern United States". J. Parasitol. 93 (3): 511-517.
Amore G, Tomassone L, Grego E, et al (March 2007). "Borrelia lusitaniae in immature Ixodes ricinus (Acari: Ixodidae) feeding on common wall lizards in Tuscany, central Italy". J. Med. Entomol. 44 (2): 303-307.
Swanson KI, Norris DE (2007). "Detection of Borrelia burgdorferi DNA in lizards from Southern Maryland". Vector Borne Zoonotic Dis. 7 (1): 42-49. doi:10.1089/vbz.2006.0548.
Majl‡thov‡ V, Majl‡th I, Derd‡kov‡ M, V’chov‡ B, Pet'ko B (December 2006). "Borrelia lusitaniae and green lizards (Lacerta viridis), Karst Region, Slovakia". Emerging Infect. Dis. 12 (12): 1895-1901. http://www.cdc.gov/ncidod/eid/vol12no12/06-0784.htm.
Li M, Masuzawa T, Takada N, et al (1998). "Lyme disease Borrelia species in northeastern China resemble those isolated from far eastern Russia and Japan". Appl. Environ. Microbiol. 64 (7): 2705-2709.
Masuzawa T (2004). "Terrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in East Asia". Jpn. J. Infect. Dis. 57 (6): 229-235.
Walder G, Lkhamsuren E, Shagdar A, et al (2006). "Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia". Int. J. Med. Microbiol. 296 Suppl 40: 69-75. doi:10.1016/j.ijmm.2006.01.031.
Mantovani E, Costa IP, Gauditano G, Bonoldi VL, Higuchi ML, Yoshinari NH (2007). "Description of Lyme disease-like syndrome in Brazil. Is it a new tick borne disease or Lyme disease variation?". Braz. J. Med. Biol. Res. 40 (4): 443-456
Yoshinari NH, Oyafuso LK, Monteiro FG, et al (1993). "Lyme disease. Report of a case observed in Brazil" (in Portuguese). Revista do Hospital das Cl’nicas 48 (4): 170-174.
Bouattour A, Ghorbel A, Chabchoub A, Postic D (2004). "Lyme borreliosis situation in North Africa" (in French). Archives de l'Institut Pasteur de Tunis 81 (1-4): 13-20.
Dsouli N, Younsi-Kabachii H, Postic D, et al (2006). "Reservoir role of lizard Psammodromus algirus in transmission cycle of Borrelia burgdorferi sensu lato (Spirochaetaceae) in Tunisia". J. Med. Entomol. 43 (4): 737-742. doi:10.1603/0022-2585(2006)43[737:RROLPA]2.0.CO;2.
Helmy N (2000). "Seasonal abundance of Ornithodoros (O.) savignyi and prevalence of infection with Borrelia spirochetes in Egypt". Journal of the Egyptian Society of Parasitology 30 (2): 607-619.
Fivaz BH, Petney TN (1989). "Lyme diseaseŃa new disease in southern Africa?". Journal of the South African Veterinary Association 60 (3): 155-158.
Jowi JO, Gathua SN (2005). "Lyme disease: report of two cases". East African medical journal 82 (5): 267-269
Piesman J, Stone BF (1991). "Vector competence of the Australian paralysis tick, Ixodes holocyclus, for the Lyme disease spirochete Borrelia burgdorferi". Int. J. Parasitol. 21 (1): 109-111. doi:10.1016/0020-7519(91)90127-S
Grubhoffer L, Golovchenko M, Vancov‡ M, Zacharovov‡-Slav’ckov‡ K, Rudenko N, Oliver JH (2005). "Lyme borreliosis: insights into tick-/host-borrelia relations". Folia Parasitol. 52 (4): 279-294.
Higgins R (2004). "Emerging or re-emerging bacterial zoonotic diseases: bartonellosis, leptospirosis, Lyme borreliosis, plague". Rev. - Off. Int. Epizoot. 23 (2): 569-581.
Ballantyne C (November 2008). "The chronic debate over Lyme disease". Nat. Med. 14 (11): 1135-9. doi:10.1038/nm1108-1135.
Whelan, David (2007-03-12). "Lyme Inc". Forbes. http://www.forbes.com/business/healthcare/forbes/2007/0312/096.html. Retrieved on 2008-06-24.
William Hathaway and Hilary Waldman (2007-03-27). "Lyme Disease Experts: Butt Out, Blumenthal". The Hartford Courant.
Landers, Susan J (2008-06-09). "Lyme treatment accord ends antitrust probe". American Medical News. http://www.ama-assn.org/amednews/2008/06/09/hlsa0609.htm
State of Connecticut Attorney General's Office (2008-05-01). Attorney General's Investigation Reveals Flawed Lyme Disease Guideline Process, IDSA Agrees To Reassess Guidelines, Install Independent Arbiter. Press release. http://www.ct.gov/ag/cwp/view.asp?a=2795&q=414284
Infectious Diseases Society of America (2008-05-01). Agreement Ends Lyme Disease Investigation By Connecticut Attorney General: Medical Validity of IDSA Guidelines Not Challenged. Press release. http://www.idsociety.org/Content.aspx?id=11182
Grann, David (2001-06-17). "Stalking Dr. Steere Over Lyme Disease". New York Times Magazine. http://www.nytimes.com/2001/06/17/magazine/17LYMEDISEASE.htm
Cooper JD, Feder HM (December 2004). "Inaccurate information about lyme disease on the internet". Pediatr. Infect. Dis. J. 23 (12): 1105-8
Steere AC, Coburn J, Glickstein L (April 2004). "The emergence of Lyme disease". J. Clin. Invest. 113 (8): 1093-101. doi:10.1172/JCI21681.
Pachner AR, Steiner I (June 2007). "Lyme neuroborreliosis: infection, immunity, and inflammation". Lancet Neurol 6 (6): 544-52. doi:10.1016/S1474-4422(07)70128-X.
Fikrig E, Narasimhan S (April 2006). "Borrelia burgdorferi--traveling incognito?". Microbes Infect. 8 (5): 1390-9. doi:10.1016/j.micinf.2005.12.022.
Xu Q, Seemanapalli SV, Reif KE, Brown CR, Liang FT (April 2007). "Increasing the recruitment of neutrophils to the site of infection dramatically attenuates Borrelia burgdorferi infectivity". J. Immunol. 178 (8): 5109-15
Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL (June 1997). "Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice". Cell 89 (7): 1111-9.
Rupprecht TA, Koedel U, Fingerle V, Pfister HW (2008). "The pathogenesis of Lyme neuroborreliosis: from infection to inflammation". Mol. Med. 14 (3-4): 205-12. doi:10.2119/2007-00091.Rupprecht.
Cabello FC, Godfrey HP, Newman SA (August 2007). "Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix". Trends Microbiol. 15 (8): 350-4. doi:10.1016/j.tim.2007.06.003.
Ramesh G, Alvarez AL, Roberts ED, et al (September 2003). "Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes". Eur. J. Immunol. 33 (9): 2539-50. doi:10.1002/eji.200323872.
Halperin JJ, Heyes MP (January 1992). "Neuroactive kynurenines in Lyme borreliosis". Neurology 42 (1): 43-50.
"Treatment of Lyme Disease". Columbia University. http://www.columbia-lyme.org/flatp/treatment.html.
Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP (1998). "The pathophysiologic roles of interleukin-6 in human disease". Ann. Intern. Med. 128 (2): 127-137.
Rasley A, Anguita J, Marriott I (2002). "Borrelia burgdorferi induces inflammatory mediator production by murine microglia". J. Neuroimmunol. 130 (1-2): 22-31. doi:10.1016/S0165-5728(02)00187-X.
Wright CB, Sacco RL, Rundek TR, et al (2006). "Interleukin-6 is associated with cognitive function: the Northern Manhattan Study". Journal of Stroke and Cerebrovascular Diseases 15 (1): 34-38. doi:10.1016/j.jstrokecerebrovasdis.2005.08.009.
Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP (2005). "Cytokine dysregulation, inflammation and well-being". Neuroimmunomodulation 12 (5): 255-269. doi:10.1159/000087104.
Calcagni E, Elenkov I (2006). "Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases". Ann. N. Y. Acad. Sci. 1069: 62-76. doi:10.1196/annals.1351.006.
Gasse T, Murr C, Meyersbach P, et al (1994). "Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy". European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 32 (9): 685-689.
Zajkowska J, Grygorczuk S, Kondrusik M, Pancewicz S, Hermanowska-Szpakowicz T (2006). "New aspects of pathogenesis of Lyme borreliosis" (in Polish). Przegl?d epidemiologiczny 60 Suppl 1: 167-170.
Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001). "Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio". Journal of clinical psychopharmacology 21 (2): 199-206. doi:10.1097/00004714-200104000-00012.
Diamond M, Kelly JP, Connor TJ (2006). "Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade". European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 16 (7): 481-490. doi:10.1016/j.euroneuro.2005.11.011.
Jarefors S, Janefjord CK, Forsberg P, Jenmalm MC, Ekerfelt C (2007). "Decreased up-regulation of the interleukin-12Rbeta2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed individuals". Clin. Exp. Immunol. 147 (1): 18-27. doi:10.1111/j.1365-2249.2006.03245.x.
Ramesh G, Philipp MT (2005). "Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins". Neurosci. Lett. 384 (1-2): 112-116. doi:10.1016/j.neulet.2005.04.069.
Singh SK, Girschick HJ (2006). "Toll-like receptors in Borrelia burgdorferi-induced inflammation". Clin. Microbiol. Infect. 12 (8): 705-717. doi:10.1111/j.1469-0691.2006.01440.x.
Weinstein A, Britchkov M (July 2002). "Lyme arthritis and post-Lyme disease syndrome". Curr Opin Rheumatol 14 (4): 383-7.
Bolz DD, Weis JJ (August 2004). "Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?". Autoimmunity 37 (5): 387-92. doi:10.1080/08916930410001713098.
Afzelius A (1910). "Verhandlungen der Dermatologischen Gesellshaft zu Stockholm" (in German). Archives of Dermatology and Syphilis 101: 100-102.
Burckhardt JL (1911). "Zur Frage der Follikel- und Keimzentrenbildung in der Haut" (in German). Frankfurter Zeitschrift fur Pathologie 6: 352-359.
Hellerstrom S (1930). "Erythema chronicum migrans Afzelii" (in German). Archiv Dermatologie and Venereologie (Stockholm) 11: 315-321.
Lenhoff C (1948). "Spirochetes in aetiologically obscure diseases". Acta Dermato-Venreol 28: 295-324.
Thyresson N (1949). "The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer)". Acta Derm. Venereol. 29 (6): 572-621.
Bianchi GE (1950). "Penicillin therapy of lymphocytoma". Dermatologica 100 (4-6): 270-273.
Paschoud JM (1954). "Lymphocytoma after tick bite" (in German). Dermatologica 108 (4-6): 435-437.
Scrimenti RJ (1970). "Erythema chronicum migrans". Archives of dermatology 102 (1): 104-105. doi:10.1001/archderm.102.1.104.
Steere AC (2006). "Lyme borreliosis in 2005, 30 years after initial observations in Lyme, Connecticut". Wien. Klin. Wochenschr. 118 (21-22): 625-633. doi:10.1007/s00508-006-0687-x.
Sternbach G, Dibble C (1996). "Willy Burgdorfer: Lyme disease". J Emerg Med 14 (5): 631-634. doi:10.1016/S0736-4679(96)00143-6.
Mast WE, Burrows WM (1976). "Erythema chronicum migrans and "Lyme arthritis"". JAMA 236 (21): 2392. doi:10.1001/jama.236.21.2392d.
Steere AC, Malawista SE, Snydman DR, et al (1977). "Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities". Arthritis Rheum. 20 (1): 7-17. doi:10.1002/art.1780200102.
Steere AC, Hutchinson GJ, Rahn DW, et al (1983). "Treatment of the early manifestations of Lyme disease". Ann. Intern. Med. 99 (1): 22-26.
Luft BJ, Volkman DJ, Halperin JJ, Dattwyler RJ (1988). "New chemotherapeutic approaches in the treatment of Lyme borreliosis". Ann. N. Y. Acad. Sci. 539: 352-361. doi:10.1111/j.1749-6632.1988.tb31869.x.
Dattwyler RJ, Volkman DJ, Conaty SM, Platkin SP, Luft BJ (1990). "Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis". Lancet 336 (8728): 1404-1406. doi:10.1016/0140-6736(90)93103-V.
Ribeiro JM, Mather TN, Piesman J, Spielman A (1987). "Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae)". J. Med. Entomol. 24 (2): 201-205.
|
Zurück zur Übersicht
|
|
|
| |
|
|
